Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Intravenous infusions in chronic pain management.

Kosharskyy B, Almonte W, Shaparin N, Pappagallo M, Smith H.

Pain Physician. 2013 May-Jun;16(3):231-49. Review.

2.

The use of intravenous lidocaine in trigeminal neuralgia pain relief and palliative care unit.

Stavropoulou E, Zis P, Vadalouca A.

Pain Physician. 2014 Mar-Apr;17(2):E235-6. No abstract available.

3.

Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.

Patil S, Anitescu M.

Pain Med. 2012 Feb;13(2):263-9. doi: 10.1111/j.1526-4637.2011.01241.x.

4.

In response.

Kosharskyy B.

Pain Physician. 2014 Mar-Apr;17(2):E235-6. No abstract available.

5.

Chronic pain following spinal cord injury.

Rekand T, Hagen EM, Grønning M.

Tidsskr Nor Laegeforen. 2012 Apr 30;132(8):974-9. doi: 10.4045/tidsskr.11.0794. Review. English, Norwegian.

6.
7.

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.

Lynch ME, Campbell F.

Br J Clin Pharmacol. 2011 Nov;72(5):735-44. doi: 10.1111/j.1365-2125.2011.03970.x. Review.

8.

A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.

Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P.

Pain Pract. 2013 Mar;13(3):239-52. doi: 10.1111/j.1533-2500.2012.00578.x. Review.

PMID:
22716295
9.
10.

Chronic pain management in dermatology: a guide to assessment and nonopioid pharmacotherapy.

Enamandram M, Rathmell JP, Kimball AB.

J Am Acad Dermatol. 2015 Oct;73(4):563-73; quiz 573-4. doi: 10.1016/j.jaad.2014.11.039. Review.

PMID:
26369840
11.

Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy.

O'Connor AB.

Pharmacoeconomics. 2009;27(2):95-112. doi: 10.2165/00019053-200927020-00002. Review.

PMID:
19254044
12.

Ketamine for acute-on-chronic pain.

Vaid P.

Can Nurse. 2013 Oct;109(8):20-1. No abstract available.

PMID:
24283148
14.

[New data for the pathomechanism of neuropathic pain: therapeutic evidences].

Tajti J, Szok D, Vécsei L.

Neuropsychopharmacol Hung. 2013 Mar;15(1):13-7. Review. Hungarian.

15.
16.

Pharmacologic management of chronic pain.

Argoff CE.

J Am Osteopath Assoc. 2002 Sep;102(9 Suppl 3):S21-7. Review.

PMID:
12356037
17.

Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.

Proctor SL, Estroff TW, Empting LD, Shearer-Williams S, Hoffmann NG.

J Addict Med. 2013 Jan-Feb;7(1):17-24. doi: 10.1097/ADM.0b013e3182738655.

PMID:
23131838
18.

Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.

McCarberg BH.

Postgrad Med. 2011 Nov;123(6):132-9. doi: 10.3810/pgm.2011.11.2503. Review.

PMID:
22104462
19.
20.

Topical analgesics in the management of acute and chronic pain.

Argoff CE.

Mayo Clin Proc. 2013 Feb;88(2):195-205. doi: 10.1016/j.mayocp.2012.11.015. Review.

PMID:
23374622
Items per page

Supplemental Content

Support Center